TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC

NCT03905967 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

336

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

PROCEDURE: TACE
DRUG: Lenvatinib

Sponsor

Sun Yat-sen University